Press Release: Dupixent® (dupilumab) approved by FDA as the first and only treatment indicated for prurigo nodularis 
BayWa r.e. Eyes Expansion of Standalone Power Systems in Australia 
Guidewire Announces $200 Million Accelerated Share Repurchase Program Press Release: Dupixent® (dupilumab) approved by FDA as the first and only treatment indicated for prurigo nodularis
Dupixent® (dupilumab) approved by FDA as the first and only treatment indicated for prurigo nodularis…
BayWa r.e. Eyes Expansion of Standalone Power Systems in Australia
PERTH, W AUSTRALIA, Sep 29, 2022 – (ACN Newswire) – BayWa r.e., the global energy…
Guidewire Announces $200 Million Accelerated Share Repurchase Program
SAN MATEO, Calif.–(BUSINESS WIRE)–Guidewire (NYSE: GWRE) today announced that as part of its previously announced…
Valneva Announces Launch of Approximately $40 Million in a Proposed Global Offering of American Depositary Shares and Ordinary Shares
Saint Herblain (France), September 28, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (the…
Aligos Therapeutics Files Response to Janssen Biopharma Lawsuit and Lodges Counterclaims Alleging Unfair Competition and Promissory Fraud
SOUTH SAN FRANCISCO, Calif., Sept. 28, 2022 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS),…
Cellectis Appoints Mark Frattini, M.D., Ph.D. as Chief Medical Officer
NEW YORK, Sept. 28, 2022 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS –…
GENFIT Reports First Half-Year 2022 Financial Results and Provides Corporate Update
Financial highlights Cash and cash equivalents totaled €209 million as of June 30, 2022 Net…
Idera Pharmaceuticals Acquires Aceragen
Acquisition includes late-stage rare disease portfolio with anticipated 2023 clinical milestones and first potential product…
Lyell Immunopharma Announces the Appointment of Rahsaan Thompson as Chief Legal Officer
SOUTH SAN FRANCISCO, Calif., Sept. 28, 2022 (GLOBE NEWSWIRE) — Lyell Immunopharma, Inc. (Nasdaq: LYEL),…
Windtree Therapeutics Announces Positive Istaroxime Phase 2 Study in Early Cardiogenic Shock (SEISMiC) Published in the European Journal of Heart Failure
WARRINGTON, Pa., Sept. 28, 2022 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology…
Avid’s Newest Pro Tools Software Release Propels Music Creativity and Productivity to New Heights for All Users
Seamless ARA 2 integration among latest innovations available now across all editions of the award-winning…
DGTL Holdings Inc. Reports New Business and Corporate Development Updates
Toronto, Ontario–(Newsfile Corp. – September 28, 2022) – DGTL Holdings Inc. (TSXV: DGTL) (“DGTL” or…
Global Care Capital Announces Change of Directors
Vancouver, British Columbia–(Newsfile Corp. – September 28, 2022) – Global Care Capital Inc. (CSE: HLTH)…
Kashifu Inuwa: Putting NITDA on the Cusp of a Revolution
LAGOS, NIGERIA, Sep 29, 2022 – (ACN Newswire) – Nothing offers a more reliable picture…
Pre-Launch Fête Celebrates Upcoming Debut of CasaWire and Expansion of The Wires Digital Marketplace Portfolio of Apps
Inspired marketplace for home design and décor builds on success of FashWire and GlossWire in…
Wave Life Sciences Highlights Therapeutic Potential for WVE-006 for Alpha-1 Antitrypsin Deficiency and Progress Bringing RNA Editing to the Clinic During Analyst and Investor Event
WVE-006 is the most advanced candidate for AATD designed to restore functional wild-type AAT protein…
Board of Directors Approves Half-Year Financial Report as of June 30, 2022
PHILOGEN S.p.A. BOARD OF DIRECTORS APPROVES HALF-YEAR FINANCIAL REPORT AS OF JUNE 30, 2022 (Courtesy…
Verizon unveils the future of 5G home entertainment during Mobile World Congress keynote
From the Network America relies on, the latest in home, gaming and entertainment revealed at…
Verizon brings NFL+ to +play platform
+play — one-of-a-kind technology exclusive to Verizon customers — will allow users to discover, purchase…
dmg media Selects Outbrain as Exclusive Recommendation Partner
Outbrain Adds Another 1.1 Billion Monthly Pageviews to its Supply Footprint NEW YORK, Sept. 28,…